We are live on ! Find out more
Charles Schwab

Charles Schwab Portfolio holdings

AUM $654B
1-Year Est. Return 26.35%
 

Charles Schwab Corporation, founded in 1971 by Charles R. Schwab and headquartered in Westlake, Texas, is a leading financial services firm that revolutionized retail investing by offering low-cost brokerage services. Initially disrupting the industry with discount commissions, it has grown into a powerhouse providing a wide array of services, including trading platforms, robo-advisors, retirement accounts, and banking products, managing hundreds of billions in client assets. Known for its user-friendly technology and customer-centric approach, Schwab caters to individual investors, financial advisors, and institutions, notably expanding through its 2020 acquisition of TD Ameritrade. With a mission to democratize investing, Charles Schwab remains a dominant force in the shift toward accessible, self-directed wealth management.

This Fund
S&P 500
This Quarter Est. Return
-2.63%
1 Year Est. Return
+26.35%
3 Year Est. Return
+83.88%
5 Year Est. Return
+111.55%
10 Year Est. Return
+435.01%
AUM
$349B
AUM Growth
-$1.04B
Cap. Flow
+$12.6B
Cap. Flow %
3.6%
Top 10 Hldgs %
18.46%
Holding
3,713
New
104
Increased
2,394
Reduced
623
Closed
137

Sector Composition

Rank Sector Weight
1 Technology 22.03%
2 Healthcare 12.31%
3 Financials 11.79%
4 Consumer Discretionary 9.84%
5 Industrials 9.11%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MAPS
3401
DELISTED
WM TECHNOLOGY INC A
MAPS
$54K ﹤0.01%
40,927
YHGJ icon
3402
Yunhong Green CTI Ltd
YHGJ
$7.54M
$53K ﹤0.01%
2,021
NNBR icon
3403
NN Inc
NNBR
$255M
$52.8K ﹤0.01%
28,401
HGBL icon
3404
Heritage Global
HGBL
$40.3M
$52.4K ﹤0.01%
16,791
INO icon
3405
Inovio Pharmaceuticals
INO
$55.7M
$51.7K ﹤0.01%
11,076
-94,004
-89% -$519K
PBYI icon
3406
Puma Biotechnology
PBYI
$404M
$51.2K ﹤0.01%
19,453
TSHA icon
3407
Taysha Gene Therapies
TSHA
$1.68B
$51K ﹤0.01%
16,140
LFT
3408
Lument Finance Trust
LFT
$34.6M
$50K ﹤0.01%
24,035
LTRX icon
3409
Lantronix
LTRX
$240M
$49.5K ﹤0.01%
11,128
KOPN icon
3410
Kopin
KOPN
$652M
$49K ﹤0.01%
40,189
ZYNE
3411
DELISTED
Zynerba Pharmaceuticals, Inc
ZYNE
$47.7K ﹤0.01%
37,596
SPRU icon
3412
Spruce Power Holding Corp
SPRU
$35.8M
$47.2K ﹤0.01%
8,683
CAPR icon
3413
Capricor Therapeutics
CAPR
$223M
$46.1K ﹤0.01%
13,479
FREE
3414
DELISTED
Whole Earth Brands, Inc. Class A Common Stock
FREE
$46K ﹤0.01%
12,768
CTV
3415
DELISTED
Innovid Corp.
CTV
$45.8K ﹤0.01%
35,745
CYT
3416
DELISTED
Cyteir Therapeutics, Inc. Common Stock
CYT
$45.4K ﹤0.01%
15,972
RSSS icon
3417
Research Solutions
RSSS
$73.6M
$44.6K ﹤0.01%
18,069
XBIT icon
3418
XBiotech
XBIT
$68M
$43.2K ﹤0.01%
10,477
ATYR
3419
aTyr Pharma
ATYR
$47.6M
$42.2K ﹤0.01%
26,689
GNSS icon
3420
Genasys
GNSS
$76.1M
$42K ﹤0.01%
20,918
ANIX icon
3421
Anixa Biosciences
ANIX
$116M
$41.8K ﹤0.01%
12,785
BDTX icon
3422
Black Diamond Therapeutics
BDTX
$96.8M
$41.6K ﹤0.01%
14,484
LPTV
3423
DELISTED
Loop Media, Inc.
LPTV
$41.4K ﹤0.01%
83,321
-173,432
-68% -$279K
SND icon
3424
Smart Sand
SND
$185M
$40.5K ﹤0.01%
17,439
APYX icon
3425
Apyx Medical
APYX
$173M
$40K ﹤0.01%
12,488

Similar funds

Charles Schwab's Q3 2023 Portfolio in Review

As of Q3 2023, Charles Schwab held 3,713 positions worth $349B, down 0.3% from $350B the previous quarter. Its ten largest holdings account for 18% of the portfolio.

Charles Schwab deployed $12.6B of net new capital in Q3 2023, opening 104 new positions and adding to 2,394 existing holdings. Its largest new stake was Vanguard Morningstar Value ETF: 2,862,740 shares worth $395M.

By sector, the portfolio is most concentrated in Technology at 22% of assets, down from 23% a quarter earlier, followed by Healthcare and Financials.

On the sell side, the largest reduction was Johnson & Johnson, an estimated $234M trimmed.

  • Charles Schwab's largest Q3 2023 buy was Vanguard Morningstar Value ETF: 2,862,740 shares worth $395M.
  • Charles Schwab added most to iShares Core US Aggregate Bond ETF in Q3 2023, an estimated $956M increase.
  • Charles Schwab's biggest Q3 2023 reduction was Johnson & Johnson, cutting an estimated $234M.
  • Charles Schwab fully exited iShares 0-5 Year TIPS Bond ETF in Q3 2023, selling an estimated $411M.
  • Charles Schwab's ten largest holdings make up 18% of its $349B portfolio in Q3 2023.
  • Charles Schwab opened 104 new positions and closed 137 in Q3 2023.
  • Charles Schwab's portfolio value fell 0.3% quarter-over-quarter to $349B.

Based on Charles Schwab's 13F filing for Q3 2023, filed 8 Nov 2023.